SRI Biosciences is ideally positioned as your single-source partner to seamlessly integrate basic research, drug discovery, and nonclinical development. We are committed to helping you achieve your goals— from Idea to IND®. Learn more about our offerings in the overview brochures below. To requested mailed copies or for more information, contact us.
SRI has been a major provider of drug discovery and development services to pharmaceutical and biotechnology companies, academia, foundations, and government agencies for more than six decades.
We offer comprehensive contract services for small molecule drugs and biologics—a one-stop solution to take your product candidates all the way through the regulatory filings to
initiate first-in-human clinical trials.
We provide a full range of standard and specialized services for both human and veterinary clinical research samples. We are fully compliant with FDA Good Laboratory Practice (GLP) regulations and use state-of-the-art instrumentation and data management systems.
Our drug formulation experience ranges from preparation of dose formulations for preclinical in vitro and in vivo safety studies to design of finished drug product dosage forms for clinical trials.
Let us provide you with expert assistance in planning and implementing the development of your lead candidate from early discovery activities through the initiation of Phase I clinical trials.
SRI researchers are attacking this huge health issue. In partnership with the National Institutes of Health (NIH), SRI Biosciences has launched a large-scale initiative to screen, evaluate, and develop new drugs and treatments for TB.
R&D Divisions